Advertising and Promotional Material Compliance and Review Process

Duration: 90 Minutes
The webinar will address requirements for compliance, "gray areas," risk assessment, opportunities for input from regulatory agencies, and review process and procedures.
Advertising and Promotional material compliance
Instructor: Peggy J. Berry
Product ID: 501369
Objectives of the Presentation
This webinar will address issues of compliance in the creation of advertising and promotional materials and the appropriate internal assurances that compliance of materials is appropriately assessed, evaluated, and documented. The information obtained will enable effectiveness and reliability of a review process for all materials. The webinar will address requirements for compliance, "gray areas," risk assessment, opportunities for input from regulatory agencies, and review process and procedures.

Why Should you Attend
Attend this training to learn about the FDA's current regulations and guidelines for advertising and promotional material compliance. Learn about industry standards for the process and procedures of an effective internal review process for materials.

Areas Covered
  • Compliance requirements
  • Submission requirements
  • Prior to approval
  • Direct to consumer
  • Social media
  • Medical affairs
  • Sales training
  • Review process considerations
Who can Benefit
This webinar can affect personnel working in:
  • Medical Affairs
  • Marketing
  • Program & Portfolio Management
  • Quality Assurance
  • Commercial/Corporate Compliance
  • Regulatory Affairs
$375
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $500.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $600.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.

Popular Courses by Peggy J. Berry

New Requirement for Electronic submission of Drug Master Files (DMFs): What you need to know

Understanding European Filing and Registration Procedures for Drug Approval

Preparing Compliant eCTD Submissions: Are you prepared for the upcoming FDA mandate on e-submissions

Similar Webinars

Combination Products-The FDA's New Codifications of the cGMP Requirements Applicable to Combination Products

Subcontractor Auditing for Pharma and Medical Device

FDA vs EU Inspections - Getting Prepared and What are Differences
Refund Policy
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held Regulatory Affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992). In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book "Choosing the Right Regulatory Career" (RAPS, MD) and author of the 2011 book "Communication & Negotiation" (RAPS, MD).
View More